Optum Epidemiology
Boston, Massachusetts, United States
Dr. Chomistek joined Optum in 2018. She earned a Master of Public Health in Epidemiology from the University of Michigan in 2006 and a ScD in epidemiology from the Harvard School of Public Health in 2011. She completed her postdoctoral training in the Department of Nutrition at the Harvard School of Public Health. Prior to joining the Epidemiology group at Optum, Dr. Chomistek was an assistant professor in the Department of Epidemiology and Biostatistics in the School of Public Health at Indiana University-Bloomington. Her prior research focused on the relationship between physical activity and cardiovascular disease. She has published her work in top cardiology journals, including the Journal of the American College of Cardiology and Circulation. Her current work at Optum is in the areas of osteoporosis, women’s health, and pregnancy.
Amgen (Contracted Research)Optum (UnitedHealth Group) (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)Singota Solutions d/b/a BioConvergence LLC (Employment)
Monday, August 23, 2021
11:45 AM – 1:30 PM US Eastern Time
OP-18E - Validity of ICD-10 Z3A Codes for Estimating Date of Last Menstrual Period
Monday, August 23, 2021
1:45 PM – 3:30 PM US Eastern Time
OP-23D - Anticoagulants and All-cause Mortality Among Hospitalized COVID-19 Patients
Tuesday, August 24, 2021
1:45 PM – 3:30 PM US Eastern Time
Tuesday, August 24, 2021
3:30 PM – 4:45 PM US Eastern Time
Wednesday, August 25, 2021
4:30 PM – 6:00 PM US Eastern Time